Microbicidal actives with virucidal efficacy against SARS-CoV-2

Am J Infect Control. 2020 Aug;48(8):972-973. doi: 10.1016/j.ajic.2020.05.015. Epub 2020 May 24.

Authors

M Khalid Ijaz¹, Kelly Whitehead², Vanita Srinivasan², Julie McKinney², Joseph R Rubino², Mark Ripley², Chris Jones², Raymond W Nims³, Bruce Charlesworth⁴

Affiliations

¹ Global Research & Development for Lysol and Dettol, Reckitt Benckiser LLC, Montvale, NJ, USA. Electronic address: Khalid.Ijaz@rb.com.
² Global Research & Development for Lysol and Dettol, Reckitt Benckiser LLC, Montvale, NJ, USA.
³ RMC Pharmaceutical Solutions, Inc., Longmont, CO, USA.
⁴ Global Medical Science, Reckitt Benckiser Health, Hull, United Kingdom.

No abstract available

Publication types

Letter

MeSH terms

Anti-Infective Agents / therapeutic use*
Antiviral Agents / therapeutic use*
Betacoronavirus / drug effects*
COVID-19
Coronavirus Infections / drug therapy*
Coronavirus Infections / prevention & control*
Humans
Pandemics / prevention & control*
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / prevention & control*
SARS-CoV-2

Substances

Anti-Infective Agents
Antiviral Agents